NEULANDLABNSENeuland Laboratories Limited· PharmaceuticalsLowNeutral
Announced Wed, 3 Jun · 15:00 IST

Intimation about Schedule of Analyst / Institutional Investor Meeting on June 8 & 9, 2026

Board & Shareholder Meetings View source PDF

NEULANDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.1%1-day move
₹16890.00
prior close
₹17014.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0-0.1+0.0+0.1-0.1-0.0+1.8+0.1+1.8+7.2+11.9
Up moveDown movePending
AI summary

Neuland Laboratories has informed the stock exchanges about its schedule for meeting with analysts and institutional investors on June 8 and June 9, 2026. The company is required to disclose such investor engagement schedules under SEBI's insider trading and disclosure norms. No specific agenda, financials, or business updates were mentioned in this intimation. The meetings will likely involve discussions on the company's performance, strategy, and outlook with select institutional participants.

Likely market impact

This is a routine compliance disclosure and by itself is not a material event. Investors should watch for any new information or guidance shared during these meetings, which could influence sentiment.